CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy

A specialized edition intended for medical institutions and doctors.

Symbiia®

Antidepressants

Duloxetine is a combined serotonin and norepinephrine reuptake inhibitor. It insignificantly inhibits dopamine uptake, has no significant affinity for histamine and dopamine, cholinergic and adrenergic receptors. The mechanism of action of duloxetine in the treatment of depression is due to inhibition of serotonin and norepinephrine reuptake and, as a result, increased serotonergic and noradrenergic neurotransmission in the central nervous system. Duloxetine also has an analgesic effect, which is probably the result of slowing the transmission of pain impulses in the central nervous system.

Apteka Bazhaemo Zdorovya

Characteristics of the productу:

Release formCapsule
PregnantWith caution
NursingContraindicated
Release categoryPrescription medication
DiabeticsWith caution
With alcoholWith caution
DriversContraindicated
Temperature storage conditionsNot higher than 25 °С
Qualitative and quantitative composition
Pharmaceutical form
Pharmacotherapeutic group
Pharmacological properties
Clinical particulars
Therapeutic indications
Contraindications
Interaction with other medicinal products and other forms of interaction
Special warnings and precautions for use
Posology and method of administration
Overdose
Undesirable effects
Shelf life
Special precautions for storage
Nature and contents of container
Category of release
Marketing authorisation holder
The marketing authorisation holder 's location and address of the place of business
Manufacturer
The manufacturer's location and address of the place of business
Date of last revision